Search Results 151-160 of 2783 for ☃구글 찌라시 ※프로그램:GTTVTT 구글유흥광고 구글웹툰광고 구글스포츠중계광고☃
The primary purpose of this study is to evaluate the safety, tolerability of single-ascending doses of BIIB100 in adults with amyotrophic lateral sclerosis (ALS) ...
This week's episode of Tomorrow's Cure comes to you from the PlatforMed Conference, held in June 2025 in Minneapolis. The event brought together more than ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. Hunhu Healthcare, a new Mayo Ventures company, plans to use mobile technology, predictive analytics, wearable technology and social ...
terms-conditions-use-policy · Blood Donor Program · Frequently asked questions · Platelet, double red blood cell and plasma donations · Minnesota Blood Donor ...
... program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics. Participation eligibility. Participant eligibility includes ...
Dr. Drazkowski is continuing to participate in device trials for people with epilepsy and their impact will be maintained as part of his research program.
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
Gretchen E. Glaser, M.D., a Mayo Clinic physician-scientist, focuses her research on optimized treatments for endometrial cancer and enhanced postoperative ...
To assess the quality of images obtained with a new RF (AIR) coil when compared to those obtained using FDA approved RF coils of patients undergoing MR imaging ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.